Navigation Links
Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
Date:12/4/2009

BETHESDA, Md., Dec. 4 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application on a system for automation of the initial stages of the manufacture of the Company's DCVax® therapeutic cancer vaccines. These initial manufacturing stages are key to the very high concentration of dendritic cells (which are the critical ingredient) in the finished DCVax® vaccine.

The current first generation (non-automated) manufacturing is highly precise, and achieves a concentration of at least 80% or more dendritic cells in the vaccines. (In contrast, various immune therapy products being developed by other parties contain much lower levels of active ingredient.) The automation system covered by the US patent maintains NWBT's very high levels of dendritic cells, while also enabling major reductions in costs and scale-up to handle large numbers of patients.

The essential active component in the DCVax® vaccine is the patient's own master immune cells, called "dendritic cells." The dendritic cells are responsible for mobilizing the entire immune system, and its many players (including T cells, B cells and the antibodies they produce, natural killer cells and others). The dendritic cells are obtained through a blood draw from the patient, with the desired cells carefully separated from the many other types of cells in the patient's blood. The more rigorously and precisely the dendritic cells are isolated, the higher the concentration of this active ingredient in the vaccine.

The automated system developed by NWBT maintains this very high level of precision and purity of dendritic cells in DCVax®. After years of development work, the system is able to consistently and reliably separate the desired cells from the many other kinds of cells in a patient's blood, despi
'/>"/>

SOURCE Northwest Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Implant Device Remotely Monitors Heart Failure Patients at Northwestern Memorials Bluhm Cardiovascular Institute
2. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
3. Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention
4. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
5. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
6. Northwestern Memorial Transplant Program Initiates New Study
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers
9. Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009
10. Talecris Biotherapeutics Receives FDA Approval for PROLASTIN(R)-C
11. Oxygen Biotherapeutics, Inc. to Webcast Shareholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... -- USPlabs has notified the Food and Drug Administration ... reports saying that a company product contains Prozac ... 2015, the Center for Drug Evaluation and Research ... of a dietary supplement product labeled as OxyElite ... with a prescription drug active ingredient, fluoxetine. USPlabs ...
(Date:2/27/2015)... Roughly three-quarters of pharmacists said they ... interchangeable biosimilar for its branded biologic counterpart if ... according to a survey published in the Academy ... Managed Care & Specialty Pharmacy (JMCP). ... would feel as confident if the products had ...
(Date:2/27/2015)... , Feb. 27, 2015 Pharmaceutical and ... managing multiple products for the same indication. This can ... that want to prevent one of their brands from ... According to recent research by benchmarking firm, Best ... as independent brands rather than together as part of ...
Breaking Medicine Technology:OEP Product Is Counterfeit 2Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2
... YORK, Oct. 12, 2011 Reportlinker.com announces ... available in its catalogue: ... APAC Region 2010-2014 ... forecast the Peripheral Vascular Devices market in ...
... 12, 2011 Leading health sciences ... freely available through UN developing world research access program ... technical and medical information products and services, today announced ... to Research4Life , a public-private partnership working to ...
Cached Medicine Technology:Peripheral Vascular Device Market in the APAC Region 2010-2014 2Elsevier Offers 950 New Health Titles to Research4Life 2Elsevier Offers 950 New Health Titles to Research4Life 3
(Date:2/28/2015)... 28, 2015 The Heart Fit Clinic ... distributor of the machine. The Heart Fit Clinic is ... like a franchise model. The goal is to scale ... heart disease. To buy External Counterpulsation machines ... help individuals through this process and achieve the desired ...
(Date:2/28/2015)... NB (PRWEB) February 28, 2015 ... center software suite for Asterisk, are pleased to announce ... highly successful 5.7 and 5.8 versions of Q-Suite, this ... well as a number of new features to the ... Q2 2015. , Q-Suite 5.9 will add features to ...
(Date:2/28/2015)... 28, 2015 National Sales ... sales, marketing and supply chain management for consumer ... is bringing its award winning solutions for thinning-damaged ... products are specifically created to combat thinning-damaged hair. ... is committed to marrying science with nature to ...
(Date:2/28/2015)... February 28, 2015 How would ... Strategic? , There are all kinds of different ... raise awareness of the advantages and applications of ... is launching a new product this spring called ... understand the connection between personality type, leadership, and ...
(Date:2/28/2015)... Javon Bea Mercy Health System CEO ... stroke capable by the State of Illinois, enabling potential ... Harvard Hospital. , The hospital was required to submit ... treat stroke according to national standards of care for ... to bypass hospitals not designated as an Emergent Stroke ...
Breaking Medicine News(10 mins):Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... and smartphone apps is providing information on tsunami zones in ... online portal and free apps provide an at-a-glance view of ... "These are potentially life-saving tools now available for free ... ocean and coastal waters in the Northwest," said Zdenka Willis, ...
... Reporter , WEDNESDAY, April 4 (HealthDay News) -- When people ... of suicide or a fatal heart attack in the days ... Using nationwide census and death registry data that covered ... in 2006, Swedish researchers tabulated the suicides and cardiovascular fatalities ...
... , THURSDAY, April 5 (HealthDay News) -- ... learning to read, a new study suggests. Researchers ... linked to problems with children,s visual attention. They said ... treatments for those with the condition. "Visual attention ...
... cancer therapies, but the design challenges are many. Northwestern ... simple but specialized nanoparticle that can deliver a drug ... feature for effective treatment. They also are the ... interact with a cancer cell,s nucleus. "Our drug-loaded ...
... News) -- Seniors with psychological distress such as depression ... a new Australian study says. Regular physical activity, ... data from nearly 100,000 Australian men and women, aged ... them were experiencing psychological distress. Compared to those ...
... with cancer have a markedly increased risk of suicide and ... diagnosis. This has been shown in a new study from ... The New England Journal of Medicine . ... cancer inevitably causes great distress and may result in other ...
Cached Medicine News:Health News:Cancer Diagnosis May Raise Odds for Suicide, Heart Attack Death 2Health News:Cancer Diagnosis May Raise Odds for Suicide, Heart Attack Death 3Health News:Study Suggests Treating Dyslexia Before Kids Learn to Read 2Health News:Tiny hitchhikers attack cancer cells 2Health News:Tiny hitchhikers attack cancer cells 3Health News:Risk of suicide and fatal heart attack immediately following a cancer diagnosis 2
... a centimeter ruler etched into the gel tray ... includes apparatus, connecting cables, three 7x10 cm gel ... three 14-well combs. The Chameleon can accomodate up ... of a maximum of 120 samples with a ...
... of a Separation-Control unit for system control ... gel staining. The optional PhastTransfer Kit quickly ... unit. Electrophoresis is performed on a thermostatic ... 0 to +70 C. Multi-step programming capability ...
... The SEA 2000 apparatus and ready-to-use gels ... for analysis of nucleic acids by submerged ... complete this system, offering full compatibility and ... Besides the SEA 2000 and a unique ...
... SEA 2000 apparatus and ready-to-use gels are ... analysis of nucleic acids by submerged gel ... this system, offering full compatibility and optimal ... the SEA 2000 and a unique staining ...
Medicine Products: